Last fall, I started working with a couple of nursing colleagues on a project which involves LinkedIn training for oncology nurses. The number one concern voiced ahead of the training by roughly a quarter of those nurses . . . and hundreds more in my personal conversations over the last year?
For Amy Berman, BS, RN, today's cancer care delivery system is a lot like the sound of 1 hand clapping: It can be out of sync and unproductive, because it fails to touch the patients it treats.
Incidence and mortality has decreased 30% over past 10 years.
Study suggests that more than half of all patients received second and third line therapies.
International researchers from seven countries conducted a prospective study to determine risk reduction of ovarian, fallopian tube, or peritoneal cancer in women with a BRCA1 or BRCA2 mutation after oophorectomy and examine other factors, such as impact of this procedure on mortality and five year survival.
Second largest drugstore chain phasing our tobacco products by 10/1/14
The FDA has granted an accelerated approval to ibrutinib (Imbruvica) as a treatment for patients with chronic lymphocytic leukemia
On February 3, 2014 the U.S. Department of Health and Human Services (HHS) enacted a rule that will give patients direct access to their laboratory results.
Pretty sure my mom would say questioning the status quo started at a very young age . . ."If I said the moon was white, you would say it was black...just to be different." I recall feeling frustrated when my kindergarten teacher did not want me to ‘color outside the lines.' Why not?
Eltrombopag (Promacta), a small molecule thrombopoietin receptor (TPOR) agonist, has received a Breakthrough Therapy designation from the FDA for the treatment of cytopenias in patients with severe aplastic anemia (SAA) who have had insufficient response to immunosuppressive therapy.
Searchable phone app provides information on herbs, complementary therapies, and more.
Social Security Administration now includes several more cancer diagnoses.
However, incidence still far surpasses the Healthy People 2020 goal.
Differences in lung cancer incidence between men and women narrow with decreasing age.
The FDA has approved the first-ever targeted therapy combination for patients with unresectable or metastatic melanoma who harbor a BRAF V600E or V600K mutation
Canadian researchers led by Salaheddin M. Mahmud, MD, PhD of the University of Manitoba conducted a study to assess the effectiveness of the quadrivalent human papillomavirus (QHPV) vaccine against cervical dysplasia.
To me, the statement means that no matter how much someone agreeing with you might try to represent you, having the unique experience of being you and being where decisions are made means volumes more. All too often, if you aren't part of the decision making, you will likely get left out, or worse yet, get served on the menu.
Neuropathy is a dose-limiting toxicity associated with oxaliplatin treatment. Clinical trials suggested that high doses of calcium and magnesium, given before and after oxaliplatin containing regimens, help prevent or reduce neuropathy. Consequently, calcium and magnesium administration was widely adopted in clinical practice.
Over 69% of the world's opioids is used by only 4 countries.
A systematic review finds limited evidence of benefit.
Goal is to identify tests and treatments of little to no benefit.
Recommendations issued by the NCI and ASCO.
IBM's computer will be used to identify effective cancer care.
Underlying mechanism for increased risk now defined.
Two question survey works as well as longer surveys.
Researchers find that patients are not referred for supportive care services.
The IOM makes 10 recommendations for improving care.
Found to be helpful for patients with head and neck cancer.
Healthcare providers have until September 23, 2013 to comply.
PACES trial will evaluate 2 drugs to prevent colon adenomas.
